Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials.

Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials.

Item
http://www.wikidata.org/entity/Q37895419
Recent advances in treatment of acute coronary syndromesRoutine early versus deferred provisional tirofiban treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention.Rationale and design of the ETN-STEP (Early administration of Tirofiban in mid to high risk patients with non-ST elevation acute coronary syndrome referred for percutaneous coronary intervention) project: A multi-center, randomized, controlled cliniIntegrin αIIbβ3: from discovery to efficacious therapeutic targetBridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial.Antiplatelet therapy in acute coronary syndromes.Selection and timing for invasive therapy in non-ST-segment-elevation acute coronary syndrome.Progress in the research of GPIIb/IIIa antagonists.The progress in the research of antiplatelet agents (1995-2017).Efficacy and safety of quadruple therapy including tirofiban in the treatment of Chinese NSTE-ACS patients failing to receive timely percutaneous coronary intervention.
P2860

Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials.

Item
http://www.wikidata.org/entity/Q37895419
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Upstream use of small-molecule ...... of randomized clinical trials.
@en
Upstream use of small-molecule ...... of randomized clinical trials.
@nl
type
label
Upstream use of small-molecule ...... of randomized clinical trials.
@en
Upstream use of small-molecule ...... of randomized clinical trials.
@nl
prefLabel
Upstream use of small-molecule ...... of randomized clinical trials.
@en
Upstream use of small-molecule ...... of randomized clinical trials.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Upstream use of small-molecule ...... of randomized clinical trials.
@en
P2093
P304
P31
P356
10.1161/CIRCOUTCOMES.110.960294
P433
P478
P50
P577
P698